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underestimation of the TPS dose calculations at intermediate 
doses needs further investigation. 
Conclusions: The EBT3-based in-vivo skin dose measurements 
revealed an unexpected agreement with the TG43-based TPS for 
the patients exposed to higher skin doses. Intermediate 
calculated doses presented a large underestimation of the 
measured doses to the skin as evaluated by the EBT3 films. The 
clinical relevance of these findings requires further study.  
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Purpose: Recent evidence demonstrating the survival benefit 
with regional nodal radiation therapy (RT) has included the 
internal mammary chain (IMC) in the treatment volume. 
However, including the IMC can increase dose to the heart and 
lungs, and this is especially challenging in patients who have 
bilateral breast cancer. Case series for adjuvant RT in bilateral 
patients have favoured VMAT, but many of these studies did not 
encompass the IMC and do not report on the integral dose to the 
heart, left anterior descending coronary artery (LAD) or lungs. 
To determine if VMAT was superior to standard 3DCRT planning 
for patients with bilateral breast cancer when the intent is to 
treat the bilateral chest walls and nodal areas, including the 
internal mammary chain (IMC) nodes, simultaneously. 
Methods and Materials: Three patients treated with mastectomy 
for bilateral, node-positive breast cancer were treated with a 7-
field mono-isocentric photon technique and direct electron field. 
The 3DCRT technique included bilateral tangents, bilateral 
supraclavicular-axillary volumes and a central, direct mixed 
photon/electron fields. Retrospectively, mono-isocentric VMAT 
plans were generated for the same volumes for each patient. 
VMAT plans using six coplanar arcs for the chest wall portion 
were summed with the adjacent static bilateral supraclavicular 
plan. Patients 1 and 2 were scanned, planned and treated using 
a deep inspiration breath hold method, while Patient 3 was 
scanned, planned and treated during normal breathing. 
Dosimetric results were compared between techniques for each 
patient. 
Results: Coverage of the target bilateral chest wall and IMCs 
(CTV) was marginally higher in the VMAT generated plans as 
compared to the 3DCRT plans (92.5-96.1% versus 87.1%-94.8%). 
Dose to the IMC (V80 IMC) was similar between planning methods 
(mean 99.3% 3DCRT versus 99.8% VMAT). Dose to the lungs, 
heart, and LAD were all lower in the 3DCRT plans. V20 for both 
lungs was a mean of 18.4% for 3DCRT versus 31.6% for VMAT 
plans. Mean heart dose was 9.6 Gy for 3DCRT versus 13.5 Gy for 
VMAT plans. Mean LAD dose was 5.6 Gy for 3DCRT versus 19.2 Gy 
for VMAT plans. 
Conclusions: Patients with bilateral breast cancer having 
adjuvant RT including the IMC received significant dose to normal 
structures. VMAT improved target coverage slightly compared to 
3DCRT, but the dose to heart, LAD and lungs were greater in 
VMAT plans, and may increase the risk of long-term cardio-
pulmonary toxicity and the rate of secondary malignancy. 
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Purpose: To review the literature on radiotherapy for patients 
with implantable electronic devices, including chest, abdomen 
and brain implants. To provide an unreported example of 
radiation near a pacemaker, where minimal dose from a later 
radiosurgery treatment was apparently additive with earlier 
higher dose treatment near the pacemaker: summed dose may 
have resulted in pacemaker failure. 
Methods and Materials: We review pacemaker guidelines, and 
case reports for deep brain stimulators (three reports, one 
article on vagus nerve stimulation devices), insulin pumps (100 
million plus patients worldwide, with one review of insulin, 
intrathecal and chemotherapy pumps), cochlear implants (300 
thousand plus patients worldwide, eight reports), and retinal 
implants (uncommon, first Canadian implant in 2014 – a single 
guideline from the manufacturer was found).  
Results: Our patient unexpectedly suffered pacemaker failure. 
The risks to other devices are largely unknown.  
Conclusions: There are gaps in the literature concerning 
treatment of patients with common implantable devices. We 
provide prudent, physics/physiology-based recommendations for 
a Canadian-care tertiary facility context for implanted devices, 
while data is lacking. 
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Purpose:  Medical students perceive a lack of formal exposure 
to oncology-related topics during their training. The purpose of 
this study is to report the impact of an oncology interest groups 
(OIG) event on medical student interest in oncology as well as 
comfort with oncology topics such as breaking bad news. 
Methods and Materials: An extracurricular OIG event was 
coordinated, through open invitation of all 60 first and second 
year students from one campus of a larger medical school. One 
physician panelist was invited from each of the following 
specialties: surgical oncology, medical oncology and radiation 
oncology. A general practice oncologist covering in-patient 
oncology was unable to attend. The two hour event included 
panel discussion of perceived pros and cons of a career in 
oncology. Medical students were provided opportunity for 
questions within the larger group setting or the three smaller 
group break-out sessions, each facilitated by a panel physician 
framing the discussion around the skill of breaking bad news. Pre- 
and post-event surveys were used to assess the effect of this 
event on medical student interest in oncology, perception of 
oncology curriculum in their training and comfort level delivering 
bad news. 
Results: The majority of attending students (n =15/17, 88%) 
responded to the survey. Student interest in pursuing an 
oncology elective increased from 47% (7/15) pre-event to 67% 
(10/15) post-event. Similarly, medical student interest in 
pursuing a career in oncology increased from 47% (7/15) pre-
event to 53% (8/15) post-event. Pre-event, medical oncology 
(7/15) and general practice oncology (2/15) were ranked as the 
most interesting specialties in oncology, while post-event 
medical oncology (5/15) and radiation oncology (5/15) ranked 
highest. While all 15 students felt that it was important to have 
a general knowledge of oncology in any practice, many students 
felt that their program did not effectively cover oncology topics 
in general (40%, 6/15) or specifically the delivery of bad news 
(47%, 7/15). Only 13% (2/15) of students felt comfortable 
delivering bad news to patients pre-event, although 80% (12/15) 
felt more comfortable post-event. Few students (4/14, 27%) felt 
they had adequate coping skills to deal with the morbidity and 
mortality seen in an oncology practice prior to the event, 
however, this increased to 73% (11/15) after the event.  
Conclusions: Oncology interest groups can increase medical 
student exposure to oncology specialties and help them explore 
oncology as a possible career choice. OIG may also serve as a way 
to further educate medical students regarding oncology topics 
such as breaking bad news, to increase their comfort level with 
such a skill that is crucial in all fields of medicine. The potential 
